Fractalkine is a key player in skeletal muscle metabolism and pathophysiology
The FEBS Journal · 2026-04 · 293 (7) · 1865-1881
DOI: 10.1111/febs.70267 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FEBS Journal, online erschienen am 25.09.2025. Verfasst von Gourabamani Swalsingh und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biotechnology, KIIT University, Bhubaneswar, India. Hauptthemen laut MEDLINE: Chemokine CX3CL1, Muscle, Skeletal, Diabetes Mellitus, Type 2, Obesity. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 100 Literaturangaben. Gefördert von: Indian Council of Medical Research, Department of Science and Technology, Ministry of Science and Technology, India, Department of Biotechnology, Ministry of Science and Technology, India.
Abstract (Originalsprache)
Fractalkine (CX3CL1) is increasingly recognised for its role in regulating the metabolism of various tissues, including skeletal muscle. The circulating level of CX3CL1 is influenced by multiple organs including the brain, adipose tissue and immune cells, with skeletal muscles emerging as a significant source. Growing evidence shows that CX3CL1 modulates muscle metabolism through autocrine and paracrine mechanisms as well as influencing properties (i.e. migration, secretion, cellular communication) of local immune cells. Within skeletal muscle, CX3CL1‐signaling is involved in the regulation of fibre‐type composition, mitochondrial remodeling, local inflammation, and regenerative capacity. These actions affect muscle plasticity and adaptability in both resting and active states. CX3CL1 also facilitates substrate uptake, particularly glucose and lipids, by interacting synergistically with insulin‐signaling pathways, especially during metabolic stress or exercise. Furthermore, CX3CL1 contributes to the coordination of skeletal muscle function with other key metabolic organs such as adipose tissue, liver and brain. Notably, CX3CL1 appears to play a role in the pathogenesis of several chronic diseases, including type 2 diabetes (T2D), obesity, cardiovascular disease (CVD), insulin resistance (IR) and arthritis. These findings underscore the relevance of CX3CL1 in both health and disease. Here, we critically assess recent advances in CX3CL1 research, including its mechanism of action, and explore its potential implications in physiological and pathological scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biotechnology, KIIT University, Bhubaneswar, India.
- Department of Cellular & Molecular Medicine, The University of Arizona College of Medicine, Tucson, AZ, USA.
ORCID-Profile: Naresh Chandra Bal
Förderung
- Indian Council of Medical Research
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of Biotechnology, Ministry of Science and Technology, India
Zitieren
APA
Swalsingh, G., Pani, P., Sadayappan, S., & Bal, N. C. (2026). Fractalkine is a key player in skeletal muscle metabolism and pathophysiology. The FEBS Journal, 293(7), 1865-1881. https://doi.org/10.1111/febs.70267
Vancouver
Swalsingh G, Pani P, Sadayappan S, Bal NC. Fractalkine is a key player in skeletal muscle metabolism and pathophysiology. The FEBS Journal. 2026;293(7):1865-1881. doi:10.1111/febs.70267
BibTeX
@article{Swalsingh2026,
author = {Swalsingh, Gourabamani and Pani, Punyadhara and Sadayappan, Sakthivel and Bal, Naresh Chandra},
title = {Fractalkine is a key player in skeletal muscle metabolism and pathophysiology},
journal = {The FEBS Journal},
year = {2026},
volume = {293},
number = {7},
pages = {1865--1881},
doi = {10.1111/febs.70267}
}
EUVIMED